Literature DB >> 34033074

Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.

Jane Kovalevich1, Maryline Santerre2, Dianne Langford3.   

Abstract

The use of primary mammalian neurons derived from embryonic central nervous system tissue is limited by the fact that once terminally differentiated into mature neurons, the cells can no longer be propagated. Transformed neuronal-like cell lines can be used in vitro to overcome this limitation. However, several caveats exist when utilizing cells derived from malignant tumors. In this context, the popular SH-SY5Y neuroblastoma cell line and its use in in vitro systems is described. Originally derived from a metastatic bone tumor biopsy, SH-SY5Y (ATCC® CRL-2266™) cells are a subline of the parental line SK-N-SH (ATCC® HTB-11™). SK-N-SH were subcloned three times; first to SH-SY, then to SH-SY5, and finally to SH-SY5Y. SH-SY5Y were deposited to the ATCC® in 1970 by June L. Biedler. Three important characteristics of SH-SY5Y cells should be considered when using these cells in in vitro studies. First, cultures include both adherent and floating cells, both types of which are viable. Few studies address the biological significance of the adherent versus floating phenotypes, but most reported studies utilize adherent populations and discard the floating cells during media changes. Second, early studies by Biedler's group indicated that the parental differentiated SK-N-SH cells contained two morphologically distinct phenotypes: neuroblast-like cells and epithelial-like cells (Ross et al., J Natl Cancer Inst 71(4):741-747, 1983). These two phenotypes may correspond to the "N" and "S" types described in later studies in SH-SY5Y by Encinas et al. (J Neurochem 75(3):991-1003, 2000). Cells with neuroblast-like morphology are positive for tyrosine hydroxylase (TH) and dopamine-β-hydroxylase characteristic of catecholaminergic neurons, whereas the epithelial-like counterpart cells lacked these enzymatic activities (Ross et al., J Natl Cancer Inst 71(4):741-747, 1983). Third, SH-SY5Y cells can be differentiated to a more mature neuron-like phenotype that is characterized by neuronal markers. There are several methods to differentiate SH-SY5Y cells and are mentioned below. Retinoic acid is the most commonly used means for differentiation and will be addressed in detail.

Entities:  

Keywords:  CNS; Differentiation; Neurobiology; Neuroblastoma; Neuron

Year:  2021        PMID: 34033074     DOI: 10.1007/978-1-0716-1437-2_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

1.  Development of a neural phenotype in differentiating ganglion cell-derived human neuroblastoma cells.

Authors:  I G Scott; K E Akerman; J E Heikkilä; K Kaila; L C Andersson
Journal:  J Cell Physiol       Date:  1986-08       Impact factor: 6.384

2.  Retinoic acid evoked-differentiation of neuroblastoma cells predominates over growth factor stimulation: an automated image capture and quantitation approach to neuritogenesis.

Authors:  P B Simpson; J I Bacha; E L Palfreyman; A J Woollacott; R M McKernan; J Kerby
Journal:  Anal Biochem       Date:  2001-11-15       Impact factor: 3.365

3.  Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones.

Authors:  J L Biedler; S Roffler-Tarlov; M Schachner; L S Freedman
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

4.  Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.

Authors:  Fernanda Martins Lopes; Rafael Schröder; Mário Luiz Conte da Frota; Alfeu Zanotto-Filho; Carolina Beatriz Müller; André Simões Pires; Rosalva Thereza Meurer; Gabriela Delevati Colpo; Daniel Pens Gelain; Flávio Kapczinski; José Cláudio Fonseca Moreira; Marilda da Cruz Fernandes; Fabio Klamt
Journal:  Brain Res       Date:  2010-04-07       Impact factor: 3.252

5.  Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells.

Authors:  Gracia López-Carballo; Lucrecia Moreno; Susana Masiá; Paloma Pérez; Domingo Barettino
Journal:  J Biol Chem       Date:  2002-05-08       Impact factor: 5.157

Review 6.  SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.

Authors:  Hong-rong Xie; Lin-sen Hu; Guo-yi Li
Journal:  Chin Med J (Engl)       Date:  2010-04-20       Impact factor: 2.628

7.  Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.

Authors:  Yuen-Ting Cheung; Way Kwok-Wai Lau; Man-Shan Yu; Cora Sau-Wan Lai; Sze-Chun Yeung; Kwok-Fai So; Raymond Chuen-Chung Chang
Journal:  Neurotoxicology       Date:  2008-11-14       Impact factor: 4.294

8.  Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype.

Authors:  Toshiaki Kume; Yuka Kawato; Fumitaka Osakada; Yasuhiko Izumi; Hiroshi Katsuki; Takayuki Nakagawa; Shuji Kaneko; Tetsuhiro Niidome; Yuki Takada-Takatori; Akinori Akaike
Journal:  Neurosci Lett       Date:  2008-08-05       Impact factor: 3.046

9.  Cholesterol supports the retinoic acid-induced synaptic vesicle formation in differentiating human SH-SY5Y neuroblastoma cells.

Authors:  Jertta-Riina Sarkanen; Jonna Nykky; Jutta Siikanen; Jyrki Selinummi; Timo Ylikomi; Tuula O Jalonen
Journal:  J Neurochem       Date:  2007-06-01       Impact factor: 5.372

10.  Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines.

Authors:  J Chen; B Chattopadhyay; G Venkatakrishnan; A H Ross
Journal:  Cell Growth Differ       Date:  1990-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.